Tempus AI (TEM) Projected to Post Quarterly Earnings on Monday

Tempus AI (NASDAQ:TEM - Get Free Report) is anticipated to announce its earnings results after the market closes on Monday, February 24th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $202.80 million for the quarter. Investors interested in registering for the company's earnings conference call can do so using this link.

Tempus AI Stock Down 11.2 %

NASDAQ:TEM traded down $8.63 during trading hours on Friday, reaching $68.09. 14,869,986 shares of the company traded hands, compared to its average volume of 14,401,848. Tempus AI has a 1 year low of $22.89 and a 1 year high of $91.45. The business's 50-day moving average price is $49.75 and its two-hundred day moving average price is $51.44. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Insider Transactions at Tempus AI

In other news, Director David R. Epstein sold 620 shares of the company's stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $41.81, for a total transaction of $25,922.20. Following the sale, the director now directly owns 27,894 shares in the company, valued at approximately $1,166,248.14. This represents a 2.17 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Ryan M. Bartolucci sold 13,770 shares of the business's stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $60.00, for a total value of $826,200.00. Following the sale, the chief accounting officer now directly owns 57,237 shares in the company, valued at $3,434,220. The trade was a 19.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 2,583,467 shares of company stock valued at $130,542,311 over the last three months.

Analysts Set New Price Targets

A number of brokerages have recently commented on TEM. TD Cowen reiterated a "buy" rating and issued a $74.00 price target (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Loop Capital decreased their target price on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a research note on Tuesday, January 14th. Wolfe Research began coverage on Tempus AI in a research note on Friday, December 13th. They issued an "outperform" rating and a $60.00 price target on the stock. William Blair lowered Tempus AI from an "outperform" rating to a "market perform" rating in a report on Wednesday, February 12th. Finally, Guggenheim assumed coverage on Tempus AI in a report on Monday, December 9th. They issued a "buy" rating and a $74.00 target price on the stock. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $58.55.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.